High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer's disease

被引:166
作者
Kuo, YM
Emmerling, MR
Lampert, HC
Hempelman, SR
Kokjohn, TA
Woods, AS
Cotter, RJ
Roher, AE
机构
[1] Sun Hlth Res Inst, Haldeman Lab Alzheimer Dis Res, Sun City, AZ 85351 USA
[2] Warner Lambert Parke Davis, Div Pharmaceut Res, Ann Arbor, MI 48106 USA
[3] Arizona Med Clin, Peoria, AZ 85381 USA
[4] Midwestern Univ, Dept Microbiol, Glendale, AZ 85308 USA
[5] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
关键词
D O I
10.1006/bbrc.1999.0552
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A previously unrecognized large pool of Ap was discovered in freshly drawn plasma of patients diagnosed with Alzheimer's disease (AD) and non-demented control subjects. This A beta pool was revealed after acid denaturation and chromatographic separation of plasma proteins followed by A beta quantitation in the 4.5 kDa fractions by europium immunoassay, The mean values of A beta 42 in the AD and control individuals amounted to 236 ng/ml and 38 ng/ml, respectively. These A beta values are on the average far higher than previously measured. Surprisingly, the circulating A beta 42 is about 16 times more abundant than A beta 40 in the AD population, Addition of A beta to freshly drawn plasma demonstrated the rapid disappearance of A beta epitopes, as detected by immunochemical techniques, suggesting either proteolytic degradation or A beta sequestration, Incubation of A beta with purified plasma proteins and lipoproteins rapidly decreases detectable levels of free A beta suggesting epitope masking as the likely mechanism. The free and protein-bound A beta b in the circulation may represent a potential source for deposition in the cerebrovasculature and brain parenchyma of AD. (C) 1999 Academic Press.
引用
收藏
页码:787 / 791
页数:5
相关论文
共 30 条
[1]   Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma [J].
Biere, AL ;
Ostaszewski, B ;
Stimson, ER ;
Hyman, BT ;
Maggio, JE ;
Selkoe, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32916-32922
[2]   Brain microvascular changes in Alzheimer's disease and other dementias [J].
Buee, L ;
Hof, PR ;
Delacourte, A .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :7-24
[3]  
DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931
[4]  
Du YS, 1997, J NEUROCHEM, V69, P299
[5]  
Fukuchi K, 1996, AM J PATHOL, V149, P219
[6]   AMYLOID-BETA PROTEIN (A-BETA) IN ALZHEIMERS-DISEASE BRAIN - BIOCHEMICAL AND IMMUNOCYTOCHEMICAL ANALYSIS WITH ANTIBODIES SPECIFIC FOR FORMS ENDING AT A-BETA-40 OR A-BETA-42(43) [J].
GRAVINA, SA ;
HO, LB ;
ECKMAN, CB ;
LONG, KE ;
OTVOS, L ;
YOUNKIN, LH ;
SUZUKI, N ;
YOUNKIN, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7013-7016
[7]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[8]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[9]   Analysis of heterogeneous beta A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay [J].
Ida, N ;
Hartmann, T ;
Pantel, J ;
Schroder, J ;
Zerfass, R ;
Forstl, H ;
Sandbrink, R ;
Masters, CL ;
Beyreuther, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22908-22914
[10]   INHIBITION OF ALZHEIMER BETA-PEPTIDE FIBRIL FORMATION BY SERUM AMYLOID-P COMPONENT [J].
JANCIAUSKIENE, S ;
DE FRUTOS, PG ;
CARLEMALM, E ;
DAHLBACK, B ;
ERIKSSON, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26041-26044